Global Transcatheter Mitral Valve Therapies (TMVT) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

July 2026 | 94 pages | ID: GAFC19BF3317EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Transcatheter Mitral Valve Therapies (TMVT) market size was valued at US$ 4445 million in 2025 and is forecast to a readjusted size of US$ 7724 million by 2032 with a CAGR of 8.4% during review period.

Transcatheter mitral valve therapies are minimally invasive structural heart devices used to treat mitral regurgitation and selected mitral valve abnormalities. They are delivered through transfemoral-transseptal, transapical or other catheter-based approaches under transesophageal echocardiography and fluoroscopic guidance to perform leaflet approximation, annular reduction, artificial chordal repair or full mitral valve replacement. These therapies primarily serve elderly, high-risk or surgery-ineligible patients by reducing procedural trauma and recovery burden while improving mitral regurgitation and cardiac function. In 2025, the global transcatheter mitral valve therapies market, measured by manufacturer revenue from implants and dedicated delivery systems, is estimated at about 135 k units, with the average selling price of around USD 32,000 per unit. The value chain of transcatheter mitral valve therapies starts with nitinol, cobalt-chromium alloys, stainless steel, PET/polyester fabrics, bovine or porcine pericardial tissue, polymer catheter materials, radiopaque materials, precision metal components and sterile packaging materials; midstream activities include the development, manufacturing, sterilization and regulatory registration of mitral clips, annuloplasty systems, chordal repair systems, replacement valves and delivery systems; downstream demand mainly comes from structural heart centers, tertiary hospitals with cardiology-surgery heart teams, cardiovascular specialty hospitals and patients with moderate-to-severe or severe mitral regurgitation.

The growth of the transcatheter mitral valve therapies market is primarily driven by the large mitral regurgitation patient pool, population aging, the expansion of heart-failure patients, the invasiveness of conventional surgery and the persistent undertreatment of high-risk patients. Historically, transcatheter mitral intervention progressed more slowly than TAVR because of complex mitral anatomy, non-circular annular geometry, variable leaflet and chordal structures, and the risk of left ventricular outflow tract obstruction. However, long-term clinical use of MitraClip has established physician confidence and reimbursement foundations, while newer repair systems such as PASCAL, DragonFly, NeoNova and SQ-Kyrin-M broaden product availability. Recent approvals of replacement systems such as SAPIEN M3, Tendyne and HighLife are creating new treatment options for patients unsuitable for TEER or surgery. As 3D TEE, CT planning, steerable delivery systems, leaflet grasping, anchoring designs and physician training mature, TMVT is expected to expand from a high-risk niche into a broader structural heart treatment pathway.

This report is a detailed and comprehensive analysis for global Transcatheter Mitral Valve Therapies (TMVT) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Transcatheter Mitral Valve Therapies (TMVT) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Transcatheter Mitral Valve Therapies (TMVT) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Transcatheter Mitral Valve Therapies (TMVT) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Transcatheter Mitral Valve Therapies (TMVT) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Transcatheter Mitral Valve Therapies (TMVT)
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Mitral Valve Therapies (TMVT) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Edwards Lifesciences, HighLife SAS, Valgen Medtech, Hangzhou Dawneo, Shanghai Shenqi, Cardiac Dimensions, NeoChord, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Transcatheter Mitral Valve Therapies (TMVT) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Edge-to-Edge Repair Systems
  • Transcatheter Mitral Valve Replacement Systems
  • Others
Market segment by Access Route
  • Transfemoral-Transseptal Systems
  • Transapical Systems
  • Transvenous Coronary Sinus Systems
  • Others
Market segment by Disease Type
  • Primary Mitral Regurgitation
  • Secondary Mitral Regurgitation
  • Others
Market segment by Application
  • Cardiovascular Specialty Hospitals
  • Tertiary General Hospitals
Major players covered
  • Abbott Laboratories
  • Edwards Lifesciences
  • HighLife SAS
  • Valgen Medtech
  • Hangzhou Dawneo
  • Shanghai Shenqi
  • Cardiac Dimensions
  • NeoChord
Market segment by region, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
  • Chapter 1, to describe Transcatheter Mitral Valve Therapies (TMVT) product scope, market overview, market estimation caveats and base year.
  • Chapter 2, to profile the top manufacturers of Transcatheter Mitral Valve Therapies (TMVT), with price, sales quantity, revenue, and global market share of Transcatheter Mitral Valve Therapies (TMVT) from 2021 to 2026.
  • Chapter 3, the Transcatheter Mitral Valve Therapies (TMVT) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
  • Chapter 4, the Transcatheter Mitral Valve Therapies (TMVT) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
  • Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
  • Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Transcatheter Mitral Valve Therapies (TMVT) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
  • Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
  • Chapter 13, the key raw materials and key suppliers, and industry chain of Transcatheter Mitral Valve Therapies (TMVT).
  • Chapter 14 and 15, to describe Transcatheter Mitral Valve Therapies (TMVT) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Edge-to-Edge Repair Systems
  1.3.3 Transcatheter Mitral Valve Replacement Systems
  1.3.4 Others
1.4 Market Analysis by Access Route
  1.4.1 Overview: Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Access Route: 2021 Versus 2025 Versus 2032
  1.4.2 Transfemoral-Transseptal Systems
  1.4.3 Transapical Systems
  1.4.4 Transvenous Coronary Sinus Systems
  1.4.5 Others
1.5 Market Analysis by Disease Type
  1.5.1 Overview: Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Disease Type: 2021 Versus 2025 Versus 2032
  1.5.2 Primary Mitral Regurgitation
  1.5.3 Secondary Mitral Regurgitation
  1.5.4 Others
1.6 Market Analysis by Application
  1.6.1 Overview: Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Cardiovascular Specialty Hospitals
  1.6.3 Tertiary General Hospitals
1.7 Global Transcatheter Mitral Valve Therapies (TMVT) Market Size & Forecast
  1.7.1 Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021 & 2025 & 2032)
  1.7.2 Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (2021-2032)
  1.7.3 Global Transcatheter Mitral Valve Therapies (TMVT) Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Abbott Laboratories
  2.1.1 Abbott Laboratories Details
  2.1.2 Abbott Laboratories Major Business
  2.1.3 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.1.4 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Abbott Laboratories Recent Developments/Updates
2.2 Edwards Lifesciences
  2.2.1 Edwards Lifesciences Details
  2.2.2 Edwards Lifesciences Major Business
  2.2.3 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.2.4 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Edwards Lifesciences Recent Developments/Updates
2.3 HighLife SAS
  2.3.1 HighLife SAS Details
  2.3.2 HighLife SAS Major Business
  2.3.3 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.3.4 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 HighLife SAS Recent Developments/Updates
2.4 Valgen Medtech
  2.4.1 Valgen Medtech Details
  2.4.2 Valgen Medtech Major Business
  2.4.3 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.4.4 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Valgen Medtech Recent Developments/Updates
2.5 Hangzhou Dawneo
  2.5.1 Hangzhou Dawneo Details
  2.5.2 Hangzhou Dawneo Major Business
  2.5.3 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.5.4 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Hangzhou Dawneo Recent Developments/Updates
2.6 Shanghai Shenqi
  2.6.1 Shanghai Shenqi Details
  2.6.2 Shanghai Shenqi Major Business
  2.6.3 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.6.4 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Shanghai Shenqi Recent Developments/Updates
2.7 Cardiac Dimensions
  2.7.1 Cardiac Dimensions Details
  2.7.2 Cardiac Dimensions Major Business
  2.7.3 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.7.4 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Cardiac Dimensions Recent Developments/Updates
2.8 NeoChord
  2.8.1 NeoChord Details
  2.8.2 NeoChord Major Business
  2.8.3 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
  2.8.4 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 NeoChord Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: TRANSCATHETER MITRAL VALVE THERAPIES (TMVT) BY MANUFACTURER

3.1 Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Transcatheter Mitral Valve Therapies (TMVT) Revenue by Manufacturer (2021-2026)
3.3 Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Transcatheter Mitral Valve Therapies (TMVT) by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Transcatheter Mitral Valve Therapies (TMVT) Manufacturer Market Share in 2025
  3.4.3 Top 6 Transcatheter Mitral Valve Therapies (TMVT) Manufacturer Market Share in 2025
3.5 Transcatheter Mitral Valve Therapies (TMVT) Market: Overall Company Footprint Analysis
  3.5.1 Transcatheter Mitral Valve Therapies (TMVT) Market: Region Footprint
  3.5.2 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
  3.5.3 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Transcatheter Mitral Valve Therapies (TMVT) Market Size by Region
  4.1.1 Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2021-2032)
  4.1.2 Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2021-2032)
  4.1.3 Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2032)
4.2 North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032)
4.3 Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032)
4.4 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032)
4.5 South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032)
4.6 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
5.2 Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Type (2021-2032)
5.3 Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
6.2 Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application (2021-2032)
6.3 Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
7.2 North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
7.3 North America Transcatheter Mitral Valve Therapies (TMVT) Market Size by Country
  7.3.1 North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2032)
  7.3.2 North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
8.2 Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
8.3 Europe Transcatheter Mitral Valve Therapies (TMVT) Market Size by Country
  8.3.1 Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2032)
  8.3.2 Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Market Size by Region
  9.3.1 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
10.2 South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
10.3 South America Transcatheter Mitral Valve Therapies (TMVT) Market Size by Country
  10.3.1 South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2032)
  10.3.2 South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Market Size by Country
  11.3.1 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
12.2 Transcatheter Mitral Valve Therapies (TMVT) Market Restraints
12.3 Transcatheter Mitral Valve Therapies (TMVT) Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Transcatheter Mitral Valve Therapies (TMVT) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transcatheter Mitral Valve Therapies (TMVT)
13.3 Transcatheter Mitral Valve Therapies (TMVT) Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
14.3 Transcatheter Mitral Valve Therapies (TMVT) Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer


LIST OF TABLES

Table 1. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Access Route, (USD Million), 2021 & 2025 & 2032
Table 3. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Disease Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 8. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Abbott Laboratories Recent Developments/Updates
Table 10. Edwards Lifesciences Basic Information, Manufacturing Base and Competitors
Table 11. Edwards Lifesciences Major Business
Table 12. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 13. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Edwards Lifesciences Recent Developments/Updates
Table 15. HighLife SAS Basic Information, Manufacturing Base and Competitors
Table 16. HighLife SAS Major Business
Table 17. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 18. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. HighLife SAS Recent Developments/Updates
Table 20. Valgen Medtech Basic Information, Manufacturing Base and Competitors
Table 21. Valgen Medtech Major Business
Table 22. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 23. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Valgen Medtech Recent Developments/Updates
Table 25. Hangzhou Dawneo Basic Information, Manufacturing Base and Competitors
Table 26. Hangzhou Dawneo Major Business
Table 27. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 28. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Hangzhou Dawneo Recent Developments/Updates
Table 30. Shanghai Shenqi Basic Information, Manufacturing Base and Competitors
Table 31. Shanghai Shenqi Major Business
Table 32. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 33. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Shanghai Shenqi Recent Developments/Updates
Table 35. Cardiac Dimensions Basic Information, Manufacturing Base and Competitors
Table 36. Cardiac Dimensions Major Business
Table 37. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 38. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Cardiac Dimensions Recent Developments/Updates
Table 40. NeoChord Basic Information, Manufacturing Base and Competitors
Table 41. NeoChord Major Business
Table 42. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 43. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. NeoChord Recent Developments/Updates
Table 45. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 46. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue by Manufacturer (2021-2026) & (USD Million)
Table 47. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 48. Market Position of Manufacturers in Transcatheter Mitral Valve Therapies (TMVT), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 49. Head Office and Transcatheter Mitral Valve Therapies (TMVT) Production Site of Key Manufacturer
Table 50. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
Table 51. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
Table 52. Transcatheter Mitral Valve Therapies (TMVT) New Market Entrants and Barriers to Market Entry
Table 53. Transcatheter Mitral Valve Therapies (TMVT) Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 55. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2021-2026) & (K Units)
Table 56. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2027-2032) & (K Units)
Table 57. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2021-2026) & (USD Million)
Table 58. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2027-2032) & (USD Million)
Table 59. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2026) & (US$/Unit)
Table 60. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2027-2032) & (US$/Unit)
Table 61. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 62. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 63. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Type (2021-2026) & (USD Million)
Table 64. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Type (2027-2032) & (USD Million)
Table 65. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2026) & (US$/Unit)
Table 66. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2027-2032) & (US$/Unit)
Table 67. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 68. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 69. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application (2021-2026) & (USD Million)
Table 70. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application (2027-2032) & (USD Million)
Table 71. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2026) & (US$/Unit)
Table 72. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2027-2032) & (US$/Unit)
Table 73. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 74. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 75. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 76. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 77. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2026) & (K Units)
Table 78. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2027-2032) & (K Units)
Table 79. North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2026) & (USD Million)
Table 80. North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2027-2032) & (USD Million)
Table 81. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 82. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 83. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 84. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 85. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2026) & (K Units)
Table 86. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2027-2032) & (K Units)
Table 87. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2026) & (USD Million)
Table 88. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 91. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 93. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Region (2027-2032) & (K Units)
Table 95. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Region (2027-2032) & (USD Million)
Table 97. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 98. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 99. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 100. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 101. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2026) & (K Units)
Table 102. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2027-2032) & (K Units)
Table 103. South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2026) & (USD Million)
Table 104. South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Type (2027-2032) & (K Units)
Table 107. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Application (2027-2032) & (K Units)
Table 109. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity by Country (2027-2032) & (K Units)
Table 111. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Transcatheter Mitral Valve Therapies (TMVT) Raw Material
Table 114. Key Manufacturers of Transcatheter Mitral Valve Therapies (TMVT) Raw Materials
Table 115. Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
Table 116. Transcatheter Mitral Valve Therapies (TMVT) Typical Customers

LIST OF FIGURES

Figure 1. Transcatheter Mitral Valve Therapies (TMVT) Picture
Figure 2. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Type in 2025
Figure 4. Edge-to-Edge Repair Systems Examples
Figure 5. Transcatheter Mitral Valve Replacement Systems Examples
Figure 6. Others Examples
Figure 7. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue by Access Route, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Access Route in 2025
Figure 9. Transfemoral-Transseptal Systems Examples
Figure 10. Transapical Systems Examples
Figure 11. Transvenous Coronary Sinus Systems Examples
Figure 12. Others Examples
Figure 13. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue by Disease Type, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Disease Type in 2025
Figure 15. Primary Mitral Regurgitation Examples
Figure 16. Secondary Mitral Regurgitation Examples
Figure 17. Others Examples
Figure 18. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Application in 2025
Figure 20. Cardiovascular Specialty Hospitals Examples
Figure 21. Tertiary General Hospitals Examples
Figure 22. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity (2021-2032) & (K Units)
Figure 25. Global Transcatheter Mitral Valve Therapies (TMVT) Price (2021-2032) & (US$/Unit)
Figure 26. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Transcatheter Mitral Valve Therapies (TMVT) by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Transcatheter Mitral Valve Therapies (TMVT) Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Transcatheter Mitral Valve Therapies (TMVT) Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. Global Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Transcatheter Mitral Valve Therapies (TMVT) Revenue Market Share by Application (2021-2032)
Figure 43. Global Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 56. France Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Region (2021-2032)
Figure 64. China Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 67. India Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Transcatheter Mitral Valve Therapies (TMVT) Consumption Value (2021-2032) & (USD Million)
Figure 84. Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
Figure 85. Transcatheter Mitral Valve Therapies (TMVT) Market Restraints
Figure 86. Transcatheter Mitral Valve Therapies (TMVT) Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Transcatheter Mitral Valve Therapies (TMVT) in 2025
Figure 89. Manufacturing Process Analysis of Transcatheter Mitral Valve Therapies (TMVT)
Figure 90. Transcatheter Mitral Valve Therapies (TMVT) Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source


More Publications